001     154421
005     20240229123101.0
024 7 _ |a 10.1016/j.jmoldx.2020.03.005
|2 doi
024 7 _ |a pmid:32247864
|2 pmid
024 7 _ |a 1525-1578
|2 ISSN
024 7 _ |a 1943-7811
|2 ISSN
024 7 _ |a altmetric:79215059
|2 altmetric
037 _ _ |a DKFZ-2020-00752
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Schmidt, Stefan
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Comparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma.
260 _ _ |a Amsterdam [u.a.]
|c 2020
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1595594607_30774
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Jun;22(6):801-810
520 _ _ |a In this manuscript we compare the expression and applicability of biomarkers, from single genes and gene signatures, identified in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) using the GeneChip Human Transcriptome Array 2.0, nCounter and real-time polymerase chain reaction (RT-PCR) analyses. Two multicentre retrospective HNSCC patient cohorts of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG), who received postoperative radiochemotherapy (PORT-C) or primary radiochemotherapy (primary RCTx) were considered. RT-PCR was performed for a limited number of 38 genes of the PORT-C cohort only. Correlations between the methods were evaluated by the Spearman rank correlation coefficient ρ. Patients were stratified based on the expression of putative cancer stem cell markers, hypoxia-associated gene signatures and a previously developed 7-gene signature. Loco-regional tumour control (LRC) was compared between these patient subgroups using log-rank tests. Gene expressions obtained from nCounter analyses were moderately correlated to GeneChip analyses (median ρ≈0.68). A higher correlation was obtained between nCounter analyses and RT-PCR (median ρ=0.84). Significant associations to LRC were observed for most of the considered biomarkers evaluated by both GeneChip and nCounter analyses. In general, all applied biomarkers (single genes and gene signatures) classified about 70% to 85% of the patients similarly. Overall, gene signatures seem to be more robust and showed a better transferability between different measurement methods.
536 _ _ |a 315 - Imaging and radiooncology (POF3-315)
|0 G:(DE-HGF)POF3-315
|c POF3-315
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Linge, Annett
|0 P:(DE-He78)81b719227985a27b1b77ed6766094319
|b 1
|u dkfz
700 1 _ |a Großer, Marianne
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Lohaus, Fabian
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Gudziol, Volker
|b 4
700 1 _ |a Nowak, Alexander
|b 5
700 1 _ |a Tinhofer, Ingeborg
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Budach, Volker
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Sak, Ali
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Stuschke, Martin
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Balermpas, Panagiotis
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Rödel, Claus
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Schäfer, Henning
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Grosu, Anca-Ligia
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Abdollahi, Amir
|0 P:(DE-He78)360c5bc2b71a849e35aca747c041dda7
|b 14
|u dkfz
700 1 _ |a Debus, Jürgen
|0 P:(DE-He78)8714da4e45acfa36ce87c291443a9218
|b 15
|u dkfz
700 1 _ |a Ganswindt, Ute
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Belka, Claus
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Pigorsch, Steffi
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Combs, Stephanie E
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Mönnich, David
|0 P:(DE-He78)a71604d1adbf3bced939fcfcf2c7ff32
|b 20
700 1 _ |a Zips, Daniel
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Baretton, Gustavo B
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Buchholz, Frank
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Baumann, Michael
|0 P:(DE-He78)933f7d725ac87378f459623783585a1f
|b 24
|u dkfz
700 1 _ |a Krause, Mechthild
|0 P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9
|b 25
|u dkfz
700 1 _ |a Löck, Steffen
|0 P:(DE-HGF)0
|b 26
700 1 _ |a DKTK-ROG
|b 27
|e Collaboration Author
773 _ _ |a 10.1016/j.jmoldx.2020.03.005
|g p. S1525157820300763
|0 PERI:(DE-600)2032654-3
|n 6
|p 801-810
|t The journal of molecular diagnostics
|v 22
|y 2020
|x 1525-1578
909 C O |o oai:inrepo02.dkfz.de:154421
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)81b719227985a27b1b77ed6766094319
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)360c5bc2b71a849e35aca747c041dda7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)8714da4e45acfa36ce87c291443a9218
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)a71604d1adbf3bced939fcfcf2c7ff32
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)933f7d725ac87378f459623783585a1f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-315
|2 G:(DE-HGF)POF3-300
|v Imaging and radiooncology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MOL DIAGN : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)DD01-20160331
|k DD01
|l DKTK DD zentral
|x 0
920 1 _ |0 I:(DE-He78)BE01-20160331
|k BE01
|l DKTK BE zentral
|x 1
920 1 _ |0 I:(DE-He78)ED01-20160331
|k ED01
|l DKTK ED ES zentral
|x 2
920 1 _ |0 I:(DE-He78)FM01-20160331
|k FM01
|l DKTK FM zentral
|x 3
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 4
920 1 _ |0 I:(DE-He78)FR01-20160331
|k FR01
|l DKTK FR zentral
|x 5
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK MU LMU zentral
|x 6
920 1 _ |0 I:(DE-He78)E210-20160331
|k E210
|l E210 Translationale Radioonkologie
|x 7
920 1 _ |0 I:(DE-He78)E050-20160331
|k E050
|l E050 KKE Strahlentherapie
|x 8
920 1 _ |0 I:(DE-He78)TU01-20160331
|k TU01
|l DKTK TU zentral
|x 9
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)DD01-20160331
980 _ _ |a I:(DE-He78)BE01-20160331
980 _ _ |a I:(DE-He78)ED01-20160331
980 _ _ |a I:(DE-He78)FM01-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)FR01-20160331
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a I:(DE-He78)E210-20160331
980 _ _ |a I:(DE-He78)E050-20160331
980 _ _ |a I:(DE-He78)TU01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21